Activated microglia release pro-inflammatory factors and calpain into the extracellular milieu, damaging surrounding neurons. Mechanistic links to progressive neurodegeneration in diseases such as Parkinson’s disease (PD) and multiple sclerosis (MS) remain however obscure. We hypothesize that persistent damaged/dying neurons may also release cytotoxic factors and calpain into the media which then activate microglia again. Thus, inflammation, neuronal damage, and microglia activation, i.e. bi-directional interaction between neurons and microglia, may be involved in the progressive neurodegeneration. We tested this hypothesis using two in vitro models: (1) the effects of soluble factors from damaged primary cortical neurons upon primary rat neuron-microglia and (2) soluble factors released from CD3/CD28 activated peripheral blood mononuclear cells (PBMCs) of MS patients on primary human neurons and microglia. The first model indicated that neurons injured with pro-inflammatory agents (IFN-γ) release soluble neurotoxic factors, including Cox-2, ROS, and calpain, thus activating microglia, which in turn released neurotoxic factors as well. This repeated microglial activation leads to persistent inflammation and neurodegeneration. The released calpain from neurons and microglia was confirmed by calpain inhibitors calpeptin or SNJ-1945 as well as μ and mcalpain knock down using siRNA technology. Our second model using activated PBMCs, a source of pro-inflammatory Th1/Th17 cytokines and calpain released from auto-reactive T cells corroborated results in human primary cell cultures and confirmed calpain to be involved in progressive MS.
These insights into reciprocal paracrine regulation of cell injury and calpain activation in the progressive phase of MS, PD, and other neurodegenerative diseases suggest potentially beneficial preventive and therapeutic strategies, including calpain inhibition